- Clinical trials involving children have begun for COVID-19 vaccines.
- Experts say this is important because children are 20 percent of the U.S. population.
- They note that it’s difficult to reach herd immunity without vaccinating children.
With clinical trials planned or underway, children might be able to start receiving COVID-19 vaccines by this fall.
Experts say that round of vaccinations could be the final step to controlling the COVID-19 pandemic.
As it stands, about 15 percent of people in the United States have received at least one dose of the COVID-19 vaccine.
Right now, the Moderna vaccine and recently approved Johnson & Johnson vaccine are only available for adults ages 18 and older. The Pfizer-BioNTech vaccine is approved for people ages 16 and older.
That means that nearly 20 percent of the U.S. population isn’t currently eligible to receive the vaccine.
Source: healthline